What we do
Stemina is the world leader in building human cellular models for toxicity screening of drug candidates, chemical compounds, cosmetic and tobacco ingredients. Our developmental toxicity assays are the only human system for assessing the risk that a compound will cause birth defects if a woman is exposed during pregnancy.
MORE ABOUT US

What we do

Toxicology

Stemina's toxicology assays are the only human in vitro assays for developmental toxicity screening.

LEARN MORE

Technologies

Stemina's metabolomics platform and expertise in cellular models can be used for custom projects.

LEARN MORE

Our Team

Stemina has assembled a world class team of scientists and experts. Meet our team.

LEARN MORE

Latest news

Nov 8

Poster: Stemina presents poster at 2017 American College of Toxicology Annual Meeting

Nov 8, 2017
Presented at the American College of Toxicology’s 38th Annual Meeting in Palm Springs, California in November 2017 by Stemina’s Associate Director of Toxicology, Jessica Palmer. Cardiac safety is one of the leading causes of late-stage compound attrition in the pharmaceutical industry and accounts for 28% of the safety related withdrawals of FDA-approved drugs from the

Read more
Oct 25

Stemina to Present a Poster at American College of Toxicology Annual Meeting

Oct 25, 2017
Jessica Palmer, Stemina’s Associate Director of Toxicology, will present a poster at the American College of Toxicology’s 38th Annual Meeting, held November 5-8, 2017 in Palm Springs, California. Anyone interested in cardiotoxicity assays is encouraged to attend. Development of a Targeted Biomarker Assay to Predict Cardiotoxicity Potential Using Metabolomics and Human Induced Stem Cell-Derived Cardiomyocytes

Read more
Oct 4

Stemina Presented at the Annual Meeting of the Northland Chapter of SOT

Oct 4, 2017
Developmental Toxicity Potency of Valproate Analogues in a Human Pluripotent Stem Cell-Based Assay Presented at the Annual Meeting of the Northland Chapter of the Society of Toxicology (September 2017) by Jessica Palmer, Associate Director of Toxicology Development and validation of alternative models for developmental toxicity testing is essential for reducing the number of animals used

Read more